CliffBio
small molecule

BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE

BENAZEPRIL HYDROCHLORIDE; HYDROCHLOROTHIAZIDE

Loss of exclusivity—loss of exclusivity
CompanyApotex →See this company's full patent-cliff portfolio

Drug detail

Brand nameBENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE
Active ingredientBENAZEPRIL HYDROCHLORIDE; HYDROCHLOROTHIAZIDE
Strength5MG;6.25MG
Dosage formTABLET
RouteORAL
ModalitySmall molecule
FDA approvalAugust 2014
Marketing statusDISCN

More from Apotex

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.